The departments of Biostatistics and Epidemiology at the UK College of Public Health welcome Dr. Josh Lambert, Assistant Professor at the University of Cincinnati, to the next EPI/BST seminar series on Thursday, March 3rd from 12pm to 1pm.
Dr. Lambert is speaking on the topic, "Using big data to identify FDA approved drugs which protect against hospitalization due to COVID-19."
Coronavirus Disease 2019 (COVID-19) is a global public health emergency. There is an urgent need for efficacious therapeutics against the disease. One potential strategy is to repurpose already existing FDA approved drugs to treat the disease.
Using a large health insurance claims database (5 million unique US adults) from 2020, we assess the degree of prophylactic protection the top 1000 most common FDA approved drugs confers against hospitalization due to COVID-19 while simultaneously adjusting for known risk factors and confounders.
In this presentation, an overview of the common pitfalls of using claims data for academic research, and methods to evade them are presented. Finally, drugs which show potentially protective effects are discussed.
The University of Kentucky College of Public Health is undergoing a review by the Council on Education for Public Health (CEPH) for re-accreditation. Part of this process includes the invitation to provide third-party comments. Anyone, including students, alumni, employers, community partners, etc., is allowed to share relevant information about the college directly with CEPH. If you would like to provide input to CEPH to inform their review, send your comments to submissions@ceph.org by May 4th, 2025.
